Chemotherapy-radiation interactions in human cervix carcinoma xenografts.

por Tonkin, K. S., Kelland, L. R., Steel, G. G.
Publicado 1988

The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

por Philip, P. A., Kaklamanis, L., Carmichael, J., Tonkin, K., Morrison, H., Gatter, K., Harris, A. L.
Publicado 1993

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.

por Philip, P. A., Carmichael, J., Tonkin, K., Buamah, P. K., Britton, J., Dowsett, M., Harris, A. L.
Publicado 1993

High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines.

por Stuart, N. S., Philip, P., Harris, A. L., Tonkin, K., Houlbrook, S., Kirk, J., Lien, E. A., Carmichael, J.
Publicado 1992

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

por Amir, E, Freedman, OC, Chia, S, Petrella, T, Dent, S, Tonkin, K, Ahmad, I, Rayson, D, Dranitsaris, G, Clemons, M
Publicado 2009

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

por Philip, P. A., Joel, S., Monkman, S. C., Dolega-Ossowski, E., Tonkin, K., Carmichael, J., Idle, J. R., Harris, A. L.
Publicado 1992